Marshall Wace’s Supernus Pharmaceuticals SUPN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-51,139
| Closed | -$1.59M | – | 2790 |
|
|
2024
Q3 | $1.59M | Sell |
51,139
-22,380
| -30% | -$698K | ﹤0.01% | 1338 |
|
|
2024
Q2 | $1.97M | Buy |
+73,519
| New | +$1.97M | ﹤0.01% | 1252 |
|
|
2022
Q1 | – | Sell |
-58,078
| Closed | -$1.7M | – | 3284 |
|
|
2021
Q4 | $1.7M | Buy |
+58,078
| New | +$1.7M | ﹤0.01% | 1684 |
|
|
2021
Q3 | – | Sell |
-74,552
| Closed | -$2.3M | – | 2815 |
|
|
2021
Q2 | $2.3M | Sell |
74,552
-44,057
| -37% | -$1.36M | 0.01% | 1076 |
|
|
2021
Q1 | $3.11M | Buy |
118,609
+17,500
| +17% | +$458K | 0.01% | 967 |
|
|
2020
Q4 | $2.54M | Sell |
101,109
-66,028
| -40% | -$1.66M | 0.01% | 778 |
|
|
2020
Q3 | $3.48M | Sell |
167,137
-253,963
| -60% | -$5.29M | 0.02% | 608 |
|
|
2020
Q2 | $10M | Buy |
421,100
+139,931
| +50% | +$3.32M | 0.07% | 265 |
|
|
2020
Q1 | $5.06M | Sell |
281,169
-38,494
| -12% | -$692K | 0.05% | 373 |
|
|
2019
Q4 | $7.58M | Sell |
319,663
-316,085
| -50% | -$7.5M | 0.05% | 352 |
|
|
2019
Q3 | $17.5M | Buy |
635,748
+77,045
| +14% | +$2.12M | 0.14% | 162 |
|
|
2019
Q2 | $18.5M | Sell |
558,703
-74,027
| -12% | -$2.45M | 0.15% | 141 |
|
|
2019
Q1 | $22.2M | Buy |
632,730
+208,766
| +49% | +$7.32M | 0.21% | 102 |
|
|
2018
Q4 | $14.1M | Buy |
423,964
+418,904
| +8,279% | +$13.9M | 0.14% | 171 |
|
|
2018
Q3 | $255K | Buy |
+5,060
| New | +$255K | ﹤0.01% | 1028 |
|
|
2016
Q2 | – | Sell |
-31,747
| Closed | -$484K | – | 1146 |
|
|
2016
Q1 | $484K | Sell |
31,747
-142,766
| -82% | -$2.18M | ﹤0.01% | 850 |
|
|
2015
Q4 | $2.35M | Buy |
+174,513
| New | +$2.35M | 0.02% | 529 |
|